UFC featherweight Diego Brandao has apparently violated the UFC's drug testing policy by failing a test for elevated marijuana metabolites. The USADA, who conducts the testing, notified the UFC of the failure and they issued the following statement:
"The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Diego Brandao of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol ("Carboxy-THC") which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected following his fight on January 2, 2016 in Las Vegas."
Brandao fought Brian Ortega on that UFC 195 card, and was submitted by the American in the third round.